Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipiodol vs Hookwire Localization for GGO Pulmonary Lesions
NCT02180568Completed
- Sponsor
- Severance Hospital
- Start
- May 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ethiodized oil in Ground-glass opacity (GGO) (2 arms), sponsored by Severance Hospital. Primary endpoint: Procedure success rate at 1 day. Started May 2014; status: completed.
02
Drugs
ethiodized oil
03
Conditions
Ground-glass opacity (GGO)
Beyond the preview
Go deeper on NCT02180568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02180568.